AYTU BioPharma
AYTU
32 hedge funds and large institutions have $6.03M invested in AYTU BioPharma in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 9 closing their positions.
12% more capital invested
Capital invested by funds: $5.39M → $6.03M (+$638K)
0.16% more ownership
Funds ownership: 0.68% → 0.84% (+0.16%)
14% less funds holding
Funds holding: 37 → 32 (-5)
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$2.96M |
| 2 |
Renaissance Technologies
New York
|
+$125K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$31.5K |
| 4 |
Goldman Sachs
New York
|
+$11.5K |
| 5 |
Two Sigma Advisers
New York
|
+$7.78K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PSC
Piper Sandler & Co
Minneapolis,
Minnesota
|
-$297K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$275K |
| 3 |
Morgan Stanley
New York
|
-$173K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$122K |
| 5 |
OQS
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
-$83K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
PFS
27
Prospera Financial Services
Dallas,
Texas
| $1K | +$622 | +25 | New |
|
|
28
Citadel Advisors
Miami,
Florida
| – | -$122K | -4,906 | Closed |
|
|
OQS
29
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
| – | -$83K | -3,062 | Closed |
|
30
Marshall Wace
London,
United Kingdom
| – | -$70K | -2,600 | Closed |
|
|
PSC
31
Piper Sandler & Co
Minneapolis,
Minnesota
| – | -$297K | -2,480 | Closed |
|
32
UBS Group
Zurich,
Switzerland
| – | -$18.2K | -732 | Closed |
|
|
EGM
33
Engineers Gate Manager
New York
| – | -$17K | -622 | Closed |
|
|
SPC
34
Sigma Planning Corp
Ann Arbor,
Michigan
| – | -$14K | -506 | Closed |
|
35
Squarepoint
New York
| – | -$14K | -504 | Closed |
|
|
CA
36
Clearstead Advisors
Cleveland,
Ohio
| – | -$2K | -71 | Closed |
|
|
MCC
37
Money Concepts Capital
Palm Beach Gardens,
Florida
| – | +$75 | +3 | New |
|
38
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | +$124 | +5 | New |
|
AYTU Hedge Fund Activity: Q1 2022 in Review
32 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q1 2022, worth a combined $6.03M — up 12% from $5.39M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of AYTU and 4 opened new positions — a net loss of 5 holders — while 12 trimmed existing stakes and 8 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $2.96M. The largest seller was Piper Sandler & Co, exiting entirely with an estimated $297K sold.
- 32 institutional investors held AYTU BioPharma (AYTU) as of Q1 2022, down from 37 in Q4 2021.
- Funds reported $6.03M of AYTU BioPharma stock for Q1 2022, up 12% quarter-over-quarter.
- 4 funds opened new AYTU BioPharma positions in Q1 2022 and 9 closed out, a net change of -5 holders.
- The largest AYTU BioPharma buyer in Q1 2022 was Armistice Capital, an estimated $2.96M added.
- The largest AYTU BioPharma seller in Q1 2022 was Piper Sandler & Co, an estimated $297K sold.
Based on aggregated 13F filings for Q1 2022.